Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2015

Open Access 01-12-2015 | Study protocol

Effectiveness of a combined strategy to improve therapeutic compliance and degree of control among patients with hypercholesterolaemia: a randomised clinical trial

Authors: Ignacio Párraga-Martínez, Joseba Rabanales-Sotos, Fernando Lago-Deibe, Juan M Téllez-Lapeira, Francisco Escobar-Rabadán, Alejandro Villena-Ferrer, Mariano Blasco-Valle, José M Ferreras-Amez, Susana Morena-Rayo, José M del Campo-del Campo, Maria Candelaria Ayuso-Raya, José J Pérez-Pascual

Published in: BMC Cardiovascular Disorders | Issue 1/2015

Login to get access

Abstract

Background

In subjects with hypercholesterolaemia, cholesterol values remain above guideline levels. One of the limiting factors to the achievement of goals in such patients is therapeutic non-adherence. The aim of this study is to assess the effectiveness of an intervention designed to improve control of hypercholesterolaemic patients, consisting of a combined strategy that would include the delivery of printed information, treatment-compliance check cards and the dispatch of text messages as complementary measures in support of the intervention at the general practitioner’s practice.

Methods/Design

A randomised, parallel-group clinical trial will be conducted at the family medicine outpatient facilities of eight health centres in three of Spain’s Autonomous Regions (Comunidades Autónomas), covering a total of 358 subjects aged 18 years or over with diagnosis of hypercholesterolaemia. Patients in the intervention group will be supplied with printed material with information on the disease and its management, mobile-telephone text messages with guideline summaries, reminders of forthcoming appointments and/or arrangements for making new appointments in the event of non-attendance, and self-report cards to check compliance with recommendations. Both groups -intervention and control- will receive routine recommendations from their physicians in accordance with current European clinical practice guidelines for hypercholesterolaemia and cardiovascular risk management. As regards the measurements to be made, the main variable is the proportion of subjects who attain the low density lipoprotein cholesterol levels set as a target across a follow-up period of 24 months. The secondary variables are as follows: adherence to recommendations on lifestyle and adherence to drug treatment; variation in lipid profiles and cardiovascular risk levels; appearance of cardiovascular events; physical activity; food consumption; smoking habit; anthropometric measures; blood pressure; health problems; use of hypolipidaemic agents; socio-demographic data; beliefs and expectations about preventive recommendations; and degree of satisfaction with the combined strategy.

Discussion

Should this intervention prove effective, a recommendation could be issued on the application of this combined strategy to subjects with hypercholesterolaemia. It is a simple, relatively inexpensive intervention.

Trial registration

ClinicalTrials.gov: NCT02314663.
Literature
1.
go back to reference Medrano MJ, Cerrato E, Boix R, Delgado-Rodriguez M: Cardiovascular risk factors in Spanish population: metaanalysis of cross-sectional studies.Med Clin (Bar) 2005, 124:606–12. 10.1157/13074389CrossRef Medrano MJ, Cerrato E, Boix R, Delgado-Rodriguez M: Cardiovascular risk factors in Spanish population: metaanalysis of cross-sectional studies.Med Clin (Bar) 2005, 124:606–12. 10.1157/13074389CrossRef
2.
go back to reference Gabriel R, Alonso M, Segura A, Tormo MJ, Artigao LM, Banegas JR, et al.: Prevalence, geographic distribution and geographic variability of major cardiovascular risk factors in Spain. Pooled analysis of data from population-based epidemiological studies: the ERICE Study.Rev Esp Cardiol 2008, 61:1030–40. 10.1157/13126043CrossRefPubMed Gabriel R, Alonso M, Segura A, Tormo MJ, Artigao LM, Banegas JR, et al.: Prevalence, geographic distribution and geographic variability of major cardiovascular risk factors in Spain. Pooled analysis of data from population-based epidemiological studies: the ERICE Study.Rev Esp Cardiol 2008, 61:1030–40. 10.1157/13126043CrossRefPubMed
3.
go back to reference Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al.: European guidelines on cardiovascular disease prevention in clinical practice: force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical prevention in clinical practice (constituted by representatives of nine societies and by invited experts).Eur J Cardiovasc Prev Rehabil 2007, 28:2375–414. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al.: European guidelines on cardiovascular disease prevention in clinical practice: force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical prevention in clinical practice (constituted by representatives of nine societies and by invited experts).Eur J Cardiovasc Prev Rehabil 2007, 28:2375–414.
4.
go back to reference Marrugat J, Solanas P, D’Agostino R, Sullivan I, Ordovas J, Cordón F, et al.: Coronary risk estimation in Spain using a calibrated Framingham function.Rev Esp Cardiol 2003, 56:253–61. 10.1016/S0300-8932(03)76861-4CrossRefPubMed Marrugat J, Solanas P, D’Agostino R, Sullivan I, Ordovas J, Cordón F, et al.: Coronary risk estimation in Spain using a calibrated Framingham function.Rev Esp Cardiol 2003, 56:253–61. 10.1016/S0300-8932(03)76861-4CrossRefPubMed
5.
go back to reference Lobos JM, Royo-bordonada M, Brotons C, Álvarez-Sala L, Armario P, Maiques A, et al.: Guía Europea de prevención cardiovascular en la práctica clínica: adaptación española del CEIPC 2008.Rev Esp Salud Pública 2008, 82:581–616. 10.1590/S1135-57272008000600002CrossRefPubMed Lobos JM, Royo-bordonada M, Brotons C, Álvarez-Sala L, Armario P, Maiques A, et al.: Guía Europea de prevención cardiovascular en la práctica clínica: adaptación española del CEIPC 2008.Rev Esp Salud Pública 2008, 82:581–616. 10.1590/S1135-57272008000600002CrossRefPubMed
6.
go back to reference National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report report of the National Cholesterol Education Program (NECP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III).Circulation 2002, 106:3143–421. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report report of the National Cholesterol Education Program (NECP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III).Circulation 2002, 106:3143–421.
7.
go back to reference Reiner Z, Catapano A, De Backer C, Graham I, Taskinen M, Wiklund O, et al.: ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).Eur Heart J 2011, 32:1769–818.CrossRefPubMed Reiner Z, Catapano A, De Backer C, Graham I, Taskinen M, Wiklund O, et al.: ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).Eur Heart J 2011, 32:1769–818.CrossRefPubMed
8.
go back to reference Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U, et al.: Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.Lancet 2009, 373:929–40. 10.1016/S0140-6736(09)60330-5CrossRefPubMed Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U, et al.: Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.Lancet 2009, 373:929–40. 10.1016/S0140-6736(09)60330-5CrossRefPubMed
9.
go back to reference Vegazo O, Banegas JR, Civeira F, Serrano Aisa P, Jiménez FJ, Luengo E, et al.: Prevalence of dyslipidemia in outpatients of the Spanish health service: the HISPALIPID Study.Med Clin (Barc) 2006, 127:331–4. 10.1157/13092314CrossRef Vegazo O, Banegas JR, Civeira F, Serrano Aisa P, Jiménez FJ, Luengo E, et al.: Prevalence of dyslipidemia in outpatients of the Spanish health service: the HISPALIPID Study.Med Clin (Barc) 2006, 127:331–4. 10.1157/13092314CrossRef
10.
go back to reference Alvarez-Sala LA, Suárez C, Mantilla T, Franch J, Ruilope LM, Banegas JR, et al.: PREVENCAT study: control of cardiovascular risk in primary care.Med Clin (Barc) 2005, 124:406–10. 10.1157/13072841CrossRef Alvarez-Sala LA, Suárez C, Mantilla T, Franch J, Ruilope LM, Banegas JR, et al.: PREVENCAT study: control of cardiovascular risk in primary care.Med Clin (Barc) 2005, 124:406–10. 10.1157/13072841CrossRef
11.
go back to reference Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U, et al.: EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.Eur J Cardiovasc Prev Rehabil 2009, 16:121–37. 10.1097/HJR.0b013e3283294b1dCrossRefPubMed Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U, et al.: EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.Eur J Cardiovasc Prev Rehabil 2009, 16:121–37. 10.1097/HJR.0b013e3283294b1dCrossRefPubMed
12.
go back to reference Waters DD, Brotons C, Chiang CW, Ferrières J, Foody J, Jukema JW, et al.: Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.Circulation 2009, 120:28–34. 10.1161/CIRCULATIONAHA.108.838466CrossRefPubMed Waters DD, Brotons C, Chiang CW, Ferrières J, Foody J, Jukema JW, et al.: Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.Circulation 2009, 120:28–34. 10.1161/CIRCULATIONAHA.108.838466CrossRefPubMed
13.
go back to reference Wood DA, Kotseva K, Connolly S, Jennings C, Mead A, Jones J, et al.: Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial.Lancet 2008, 371:1999–2012. 10.1016/S0140-6736(08)60868-5CrossRefPubMed Wood DA, Kotseva K, Connolly S, Jennings C, Mead A, Jones J, et al.: Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial.Lancet 2008, 371:1999–2012. 10.1016/S0140-6736(08)60868-5CrossRefPubMed
14.
go back to reference Reiner Z, Sonicki Z, Tedeschi-Reiner E: Public perceptions of cardiovascular risk factors in Croatia: the PERCRO survey.Prev Med 2010, 51:494–6. 10.1016/j.ypmed.2010.09.015CrossRefPubMed Reiner Z, Sonicki Z, Tedeschi-Reiner E: Public perceptions of cardiovascular risk factors in Croatia: the PERCRO survey.Prev Med 2010, 51:494–6. 10.1016/j.ypmed.2010.09.015CrossRefPubMed
15.
go back to reference Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J: Long-term persistence in use of statin therapy in elderly patients.JAMA 2002, 288:455–61. 10.1001/jama.288.4.455CrossRefPubMed Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J: Long-term persistence in use of statin therapy in elderly patients.JAMA 2002, 288:455–61. 10.1001/jama.288.4.455CrossRefPubMed
16.
go back to reference Bermingham M, Hayden J, Dawkins I, Miwa S, Gibson D, McDonald K, et al.: Prospective analysis of LDL-C goal achievement and self-reported medication adherence among statin users in primary care.Clin Ther 2011,33(9):1180–9. 10.1016/j.clinthera.2011.07.007CrossRefPubMed Bermingham M, Hayden J, Dawkins I, Miwa S, Gibson D, McDonald K, et al.: Prospective analysis of LDL-C goal achievement and self-reported medication adherence among statin users in primary care.Clin Ther 2011,33(9):1180–9. 10.1016/j.clinthera.2011.07.007CrossRefPubMed
18.
go back to reference Bueno M, Barrionuevo MD, Fikri N, García-Jiménez E: Causes of non-compliance of patients who attend a community pharmacy in Granada.Aten Primaria 2008, 40:101–6. Bueno M, Barrionuevo MD, Fikri N, García-Jiménez E: Causes of non-compliance of patients who attend a community pharmacy in Granada.Aten Primaria 2008, 40:101–6.
19.
go back to reference Gil-Guillén V, Merino-Sánchez J, Sánchez-Ruiz T, Amorós-Barber T, Aznar-Vicente J, Abellán-Alemán J, et al.: Valoración del riesgo cardiovascular en la fase transversal del estudio Mediterránea.Rev Clin Esp 2009, 209:211–20. 10.1016/S0014-2565(09)71237-8CrossRefPubMed Gil-Guillén V, Merino-Sánchez J, Sánchez-Ruiz T, Amorós-Barber T, Aznar-Vicente J, Abellán-Alemán J, et al.: Valoración del riesgo cardiovascular en la fase transversal del estudio Mediterránea.Rev Clin Esp 2009, 209:211–20. 10.1016/S0014-2565(09)71237-8CrossRefPubMed
20.
go back to reference Banegas JR, López-García E, Dallongeville J, Guallar E, Halcox JP, Borghi C, et al.: Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study.Eur Heart J 2011,32(17):2143–52. 10.1093/eurheartj/ehr080CrossRefPubMedPubMedCentral Banegas JR, López-García E, Dallongeville J, Guallar E, Halcox JP, Borghi C, et al.: Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study.Eur Heart J 2011,32(17):2143–52. 10.1093/eurheartj/ehr080CrossRefPubMedPubMedCentral
21.
go back to reference Márquez E, Casado JJ, Corchado Y, Chaves R, Grancío A, Losada C, et al.: Eficacia de una intervención para mejorar el cumplimiento terapéutico en las dislipemias.Aten Primaria 2004,33(8):443–50. 10.1016/S0212-6567(04)79430-5CrossRef Márquez E, Casado JJ, Corchado Y, Chaves R, Grancío A, Losada C, et al.: Eficacia de una intervención para mejorar el cumplimiento terapéutico en las dislipemias.Aten Primaria 2004,33(8):443–50. 10.1016/S0212-6567(04)79430-5CrossRef
22.
go back to reference Márquez E, Gil V, Casado JJ, Martel N, de la Figuera M, Martin JL, et al.: Análisis de estudios publicados sobre el incumplimiento terapéutico en el tratamiento de la hipertensión arterial en España entre los años 1984–2005.Aten Primaria 2006, 38:325–32. 10.1157/13093369CrossRef Márquez E, Gil V, Casado JJ, Martel N, de la Figuera M, Martin JL, et al.: Análisis de estudios publicados sobre el incumplimiento terapéutico en el tratamiento de la hipertensión arterial en España entre los años 1984–2005.Aten Primaria 2006, 38:325–32. 10.1157/13093369CrossRef
23.
go back to reference Sclar DA, Chin A, Skaer TL, Okamoto MP, Nakahiro RK, Gill MA: Effect of health education in promoting prescription refill compliance among patients with hypertension.Clin Ther 1991, 13:489–95.PubMed Sclar DA, Chin A, Skaer TL, Okamoto MP, Nakahiro RK, Gill MA: Effect of health education in promoting prescription refill compliance among patients with hypertension.Clin Ther 1991, 13:489–95.PubMed
24.
go back to reference Palop V, Martínez I: Adherencia al tratamiento en el paciente anciano.Inf Ter Sist Nac Salud 2004, 28:113–20. Palop V, Martínez I: Adherencia al tratamiento en el paciente anciano.Inf Ter Sist Nac Salud 2004, 28:113–20.
25.
go back to reference McDonald P, Garg AX, Haynes RB: Intervention to enhance patient adherente to medication prescriptions (SR).JAMA 2002, 288:2868–79. 10.1001/jama.288.22.2868CrossRefPubMed McDonald P, Garg AX, Haynes RB: Intervention to enhance patient adherente to medication prescriptions (SR).JAMA 2002, 288:2868–79. 10.1001/jama.288.22.2868CrossRefPubMed
26.
go back to reference Gibbs S, Waters WE, George CF: The beneficits of prescription information leaflets.Br J Clin Pharmacol 1989, 27:723–73. 10.1111/j.1365-2125.1989.tb03434.xCrossRefPubMedPubMedCentral Gibbs S, Waters WE, George CF: The beneficits of prescription information leaflets.Br J Clin Pharmacol 1989, 27:723–73. 10.1111/j.1365-2125.1989.tb03434.xCrossRefPubMedPubMedCentral
27.
go back to reference Baker D, Roberts DE, Newcombe RG, Fox KA: Evaluation of drug information for cardiology patients.Br J Clin Pharmacol 1991, 31:525–31. 10.1111/j.1365-2125.1991.tb05574.xCrossRefPubMedPubMedCentral Baker D, Roberts DE, Newcombe RG, Fox KA: Evaluation of drug information for cardiology patients.Br J Clin Pharmacol 1991, 31:525–31. 10.1111/j.1365-2125.1991.tb05574.xCrossRefPubMedPubMedCentral
28.
go back to reference Varma S, McElnay JC, Hughes CM, Passmore AP, Varma M: Pharmaceutical care of patients with congestive heart failure: interventions and outcomes.Pharmacoterapy 1999, 19:860–9. 10.1592/phco.19.10.860.31565CrossRef Varma S, McElnay JC, Hughes CM, Passmore AP, Varma M: Pharmaceutical care of patients with congestive heart failure: interventions and outcomes.Pharmacoterapy 1999, 19:860–9. 10.1592/phco.19.10.860.31565CrossRef
29.
go back to reference Erickson SR, Slaughter R, Halapy H: Pharmacists’ ability to influence outcomes of hypertension therapy.Pharmacotherapy 1997, 17:140–7.PubMed Erickson SR, Slaughter R, Halapy H: Pharmacists’ ability to influence outcomes of hypertension therapy.Pharmacotherapy 1997, 17:140–7.PubMed
30.
go back to reference Faulkner MA, Wadibia EC, Lucas BD, Hilleman DE: Impact of pharmacy counseling on compliance and effectiveness of combination lipidlowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial.Pharmacotherapy 2000, 20:410–6. 10.1592/phco.20.5.410.35048CrossRefPubMed Faulkner MA, Wadibia EC, Lucas BD, Hilleman DE: Impact of pharmacy counseling on compliance and effectiveness of combination lipidlowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial.Pharmacotherapy 2000, 20:410–6. 10.1592/phco.20.5.410.35048CrossRefPubMed
31.
go back to reference Bodiya A, Vorias D, Dickson HA: Does telephone contac with a physicians’s office staff improve mammogram screening rates?Fam Med 1999, 31:324–6.PubMed Bodiya A, Vorias D, Dickson HA: Does telephone contac with a physicians’s office staff improve mammogram screening rates?Fam Med 1999, 31:324–6.PubMed
32.
go back to reference Batalla C: Comentario: una herramienta más para mejorar el cumplimiento terapéutico.Aten Primaria 2009, 41:191–2. 10.1016/j.aprim.2008.12.005CrossRef Batalla C: Comentario: una herramienta más para mejorar el cumplimiento terapéutico.Aten Primaria 2009, 41:191–2. 10.1016/j.aprim.2008.12.005CrossRef
33.
go back to reference Haynes RB, McKibbon KA, Kanani R, Brouwers C, Oliver T: Interventions to assist patients to follow prescriptions for medications. In Cochrane collaboration: cochrane library. Oxford: Update Software; 1998. Haynes RB, McKibbon KA, Kanani R, Brouwers C, Oliver T: Interventions to assist patients to follow prescriptions for medications. In Cochrane collaboration: cochrane library. Oxford: Update Software; 1998.
Metadata
Title
Effectiveness of a combined strategy to improve therapeutic compliance and degree of control among patients with hypercholesterolaemia: a randomised clinical trial
Authors
Ignacio Párraga-Martínez
Joseba Rabanales-Sotos
Fernando Lago-Deibe
Juan M Téllez-Lapeira
Francisco Escobar-Rabadán
Alejandro Villena-Ferrer
Mariano Blasco-Valle
José M Ferreras-Amez
Susana Morena-Rayo
José M del Campo-del Campo
Maria Candelaria Ayuso-Raya
José J Pérez-Pascual
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2015
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/1471-2261-15-8

Other articles of this Issue 1/2015

BMC Cardiovascular Disorders 1/2015 Go to the issue